Ludwig Cancer Research was proud to support six young scientists presenting their research at the conference this year through the AACR Scholar-in-Training Awards program, contributing to the cost of their travel and attendance at the conference. The SITA awards, as the AACR notes, “recognize outstanding young investigators presenting meritorious proffered papers” at the meeting. Award recipients were selected based on their CVs, personal statements and quality of research. Among the winners pictured above are, from left:
Jonathan Downie of Harvard Medical School/Massachusetts General Hospital, whose abstract was titled The effect of aspirin on the transcriptional landscape of the colon
Susana Castro Pando of the University of Texas MD Anderson Cancer Center, whose abstract was titled IL-17/IL-17RA signaling in the pancreatic epithelium upregulates B7-H4 to promote tumorigenesis
Pat Morin, deputy scientific director of the Ludwig Institute for Cancer Research
Robert Vonderheide, chair of the program committee for AACR 2023; Director of the Abramson Cancer Center, University of Pennsylvania
Carli Stewart of the Mayo Clinic, whose abstract was titled IL-4 depletion leads to the improvement of CART cell therapy
Jaime Schneider of Massachusetts General Hospital/Harvard Medical School, whose abstract was titled GUK1 is a novel metabolic liability in oncogene-driven lung cancer
Alvaro Curiel Garcia of Columbia University Irving Medical Center, whose abstract was titled BMAL2 is a KRAS-dependent master regulator of hypoxic response in pancreatic ductal adenocarcinoma
Not pictured: Brendan Heiden of Washington University in St. Louis, whose abstract was titled Comprehensive validation of high-risk clinicopathologic features in early-stage, node-negative non-small cell lung cancer